Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Depreciation and Depletion (2022 - 2026)

Revolution Medicines has reported Depreciation and Depletion over the past 4 years, most recently at $2.1 million for Q4 2025.

  • For Q4 2025, Depreciation and Depletion rose 50.0% year-over-year to $2.1 million; the TTM value through Dec 2025 reached $7.4 million, up 21.31%, while the annual FY2025 figure was $7.4 million, 19.35% up from the prior year.
  • Depreciation and Depletion for Q4 2025 was $2.1 million at Revolution Medicines, up from $2.0 million in the prior quarter.
  • Over five years, Depreciation and Depletion peaked at $2.1 million in Q4 2025 and troughed at $900000.0 in Q1 2022.
  • A 4-year average of $1.4 million and a median of $1.4 million in 2023 define the central range for Depreciation and Depletion.
  • On a YoY basis, Depreciation and Depletion climbed as much as 50.0% in 2025 and fell as far as 6.25% in 2025.
  • Year by year, Depreciation and Depletion stood at $1.2 million in 2022, then rose by 10.88% to $1.3 million in 2023, then increased by 7.28% to $1.4 million in 2024, then skyrocketed by 50.0% to $2.1 million in 2025.
  • Business Quant data shows Depreciation and Depletion for RVMD at $2.1 million in Q4 2025, $2.0 million in Q3 2025, and $1.7 million in Q2 2025.